Navigation Links
FDA Commissioner Margaret Hamburg, Bestselling Author Jim Collins to Keynote RAPS Annual Conference in Philadelphia
Date:8/28/2009

Conference to Examine Latest in Healthcare Product Regulation, Trends, Technology

ROCKVILLE, Md., Aug. 28 /PRNewswire-USNewswire/ -- Professionals concerned with developing and bringing safe and effective drugs, medical devices, biotechnology and other healthcare products to the worldwide market will convene in Philadelphia next month for the Regulatory Affairs Professionals Society's (RAPS) 2009 Annual Conference & Exhibition. Attendees will come from around the world for what is the largest annual event of its kind exclusively for regulatory professionals in the healthcare product sector.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070314/DCW091LOGO )

New US Food and Drug Administration (FDA) Commissioner Margaret Hamburg, MD, who has gained attention since taking office for her public statements about refocusing FDA on its public health mission, will address attendees as this year's closing keynote speaker. The 2009 RAPS Annual Conference & Exhibition, the theme of which is "Succeed in the New Regulatory Landscape," will take place at Philadelphia's Pennsylvania Convention Center, 13-16 September. Bestselling business author Jim Collins of Good to Great fame will open the conference's first official day of sessions with a keynote address on Monday, 14 September. For more information and a complete listing of conference sessions and events, visit www.raps.org/ac2009. Follow conference updates on Twitter at @RAPSAnnualConf.

"Regulatory professionals play a vital role in ensuring access to safe and effective medicines, medical devices and myriad other healthcare products by the patients and healthcare professionals who need them every day," said RAPS Executive Director Sherry Keramidas, PhD, CAE. "It may not be thoroughly understood by the typical consumer, but these dedicated professionals are involved at every stage of healthcare product development and marketing. This conference is the premier event for regulatory professionals to gather, learn, network and hear from high-profile speakers like Dr. Hamburg and Jim Collins."

In addition to the keynote speakers, the conference will feature more than 25 additional senior FDA officials presenting at various sessions and briefings, as well as representatives from Japan's Ministry of Health Labor and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA), the Drugs Controller General of India (DCGI) and the Dutch Healthcare Inspectorate as well as many other healthcare and regulatory experts from around the world.

Among the topics to be examined at the conference are regulation of biosimilars; considerations for clinical trials of stem cell products; regulations governing counter-bioterrorism agents; health technology assessment and its relationship to comparative effectiveness research; global clinical trials; international regulatory considerations for drugs, devices, biotechnology and combination products; regulatory challenges in emerging markets; advertising and promotion; postmarket surveillance and more. Attendees also will receive briefings from representatives of FDA's Center for Devices and Radiological Health (CDRH) and Center for Drug Evaluation and Research (CDER), the European Medicines Agency (EMEA) and Health Canada.

Members of the working media wishing to cover all or part of the 2009 RAPS Annual Conference & Exhibition should contact RAPS Communications Manager Zachary Brousseau at zbrousseau@raps.org or +1 301 770 2920, ext. 245. On-site registration also will be available and members of the media must bring valid press credentials or a letter from an assigning editor on company letterhead.

Conference sponsors include: Anson Group, BSI Healthcare, Crimson/Transperfect, Elsevier Business Intelligence, GE Healthcare, Kendle, Prolifiq Software, Stericycle and Tarius.

About RAPS

The Regulatory Affairs Professionals Society (RAPS) is an international membership organization of regulatory professionals in the rapidly growing medical device, pharmaceutical and biotechnology sectors. Regulatory professionals play vital roles in making better healthcare products possible. They work throughout the healthcare product lifecycle, ensuring these products are safe and effective, while driving organizational strategy and sound decision-making. RAPS supports these individuals and the regulatory profession by providing education and training, Regulatory Affairs Certification (RAC), professional standards, research, knowledge-sharing, publications, networking, career development opportunities and other valuable resources; and is committed to helping its members continually develop the knowledge and skills they need to excel. RAPS is headquartered near Washington, DC, with offices in Brussels and Tokyo. RAPS.org


'/>"/>
SOURCE Regulatory Affairs Professionals Society (RAPS)
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
2. Governor Rendell Directs Insurance Commissioner to Delay Mcare Abatement Collection
3. Providing Affordable Health Care Coverage Cited as a Top Priority, Commissioner Says
4. Council on Education in Management Announces Insurance Commissioner Steve Poizner Will Present Keynote Address at the 6th Annual California Workers' Comp Forum
5. Council on Education in Management Announces New Commissioner Rod Bordelon will Present a Keynote Address at the 5th Annual Texas Workers' Comp Forum
6. Insurance Commissioner Announces Retirement of George Hoover
7. Kansas Insurance Commissioner, Sandy Praeger, to Appear this Saturday on Cary Hall's Health Insurance Advocate Radio Show
8. Pennsylvania Insurance Commissioner Welcomes U.S. House Vote to Reauthorize Childrens Health Care
9. Light Sciences Oncology Elects Former FDA Commissioner Frank Young, M.D., Ph.D., to Board of Directors
10. Pennsylvania Insurance Commissioner Praises Federal Reauthorization of Childrens Health Care
11. AstraZeneca Applauds Appointment of New FDA Commissioner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2016)... ... 2016 , ... In a part of the city where’s it’s easy to spot the neon ... is hoping to attract diners with a taste for real food. , On ... doors to Cornerstone Grill, an urban casual restaurant focusing on dishes made by hand with ...
(Date:5/27/2016)... NJ (PRWEB) , ... May 27, 2016 , ... Two ... named as YWCA Tribute to Women and Industry (TWIN) 2016 honorees. The award ... their workplace. For this year, Geri Boone, Director of the MLTSS (Managed Long-Term Services ...
(Date:5/27/2016)... ... , ... With over 60 percent of acute stroke survivors being left unable ... aid in the rehabilitation process has steadily increased. Ekso Bionics had been working to ... to stroke. , Ekso Bionics has now received clearance from the U.S. Food and ...
(Date:5/27/2016)... York, NY (PRWEB) , ... May 27, 2016 ... ... partnered with Mediaplanet to help educate the many who are unaware of the ... dedicated to aphasia will run within the “Stroke Awareness” campaign. , The link ...
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, 2016 , ... ... bolstered by inspiring human interest stories, which come courtesy of leaders in the nursing ... within the industry, from leading advocates and associations—namely Abilene Christian University. , As ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient dringenden ... Brustkrebs   QIAGEN N.V. (NASDAQ: ... heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit Therawis ... für die Onkologie eingegangen zu sein. Ein erstes ...
(Date:5/25/2016)... 25, 2016 As illustrated by ... this month, the numbers and momentum of cannabis in ... into the billions, more research and development push the ... State of Legal Marijuana Markets Report  from from ArcView ... much of the increase in sector is attributed to ...
(Date:5/25/2016)... ReportsnReports.com adds "Chronic Cough ... provides an overview on therapeutic pipeline of Chronic ... therapeutics assessment by drug target, mechanism of action ... along with latest updates, and featured news and ... in the therapeutic development for Chronic Cough and ...
Breaking Medicine Technology: